Diligence memo · auto-generated · as of July 2, 2026
Revascular Therapeutics Inc
Revascular Therapeutics Inc looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Revascular Therapeutics Inc operates in Other, based in SUNNYVALE.
Sector still resolves to a broad 'Other' bucket, so operating comparables below are weaker than for a tightly-classified peer.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Revascular Therapeutics Inc has raised $26M in disclosed capital across 5 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $7.2M on 2008-06-27.
Most recent recorded round closed around 2008-06-27.
Valuation (modeled)modeled
Provath models Revascular Therapeutics Inc at approximately $110M (range $9.9M–$595M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.12× the median modeled value of Series A Other companies in 2007–2009 (168 peers) — value vs value, same stage and era. Within the normal band (112% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 18.0 yr ago; this sector typically re-raises about every 11 months.
Silent for over 3× the sector's normal cadence.
The last round was 1.3× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 88% of Other peers (25015 compared).
Modeled value ranks above 84% of those peers.
Closest niche peers: Osiris Holdings, LLC, C3 Acquisition Co. LLC, NARS Holding Company, Inc., LBC Western, Inc., Grid Net Inc.
Peoplefiled
6 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Broad sector classification weakens peer comparison.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.